SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Quoin Pharmaceuticals, Ltd. (QNRX) (CIK 0001671502) (QNRX) — Feb 6, 2019

Quoin Pharmaceuticals, Ltd. (QNRX) (CIK 0001671502)
Date: Feb. 6, 2019 · CIK: 0001671502 · Accession: 0001213900-19-001763

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-229083

Date
February 6, 2019
Author
Thomas Higgins
Form
CORRESP
Company
Quoin Pharmaceuticals, Ltd. (QNRX) (CIK 0001671502)

Letter

RE: Cellect Biotechnology Ltd. (CIK: 0001671502)

February 6, 2019

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Registration Statement No. 333-229083 on Form F-1 (the “Registration Statement”)

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), Alliance Global Partners, as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time, February 7, 2019, or as soon thereafter as practicable.

Pursuant to Rule 460 under the Securities Act, please be advised that we, acting on behalf of the several underwriters, will distribute as many electronic copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution.

By: ALLIANCE GLOBAL PARTNERS

By: /s/ Thomas Higgins

Name: Thomas Higgins

Title: Managing Director, Investment Banking

Show Raw Text
CORRESP
1
filename1.htm

February 6, 2019

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

    RE:
    Cellect Biotechnology Ltd. (CIK: 0001671502)

    Registration Statement No. 333-229083
    on Form F-1 (the “Registration Statement”)

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules
and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities
Act”), Alliance Global Partners, as representative of the underwriters, hereby requests acceleration of the effective date
of the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time, February 7, 2019, or
as soon thereafter as practicable.

Pursuant to Rule 460 under the Securities Act,
please be advised that we, acting on behalf of the several underwriters, will distribute as many electronic copies of the proposed
form of preliminary prospectus as appears to be reasonable to secure adequate distribution.

    By:
    ALLIANCE GLOBAL PARTNERS

    By:
    /s/
Thomas Higgins

    Name: Thomas Higgins

    Title: Managing
Director, Investment Banking